General Warning Notices And Recommandations - b-intense MED Bedienungsanleitung

General warning notices and recommandations

Make sure that liquids do not come
into contact with the heaters or with
the timber facings.
Avoid any contact with the heater while it
is in operation and immediately afterwards.
The high surface temperature of the heater
can cause burns.
Allow the infrared heater to cool down for
9 minutes before re-starting the cabin.
Do not stare at an infrared heater for
more than 9 minutes. We recommend
safety glasses for sensible eyes (at least
protection level 4-4 by EN 171).
Do not use the infrared cabin within 24
hours after UV irradiation from an artifi-
cial source (e.g. solarium) or sunbathing.
We recommend a warm shower and a
nurturing, moisturizing lotion after the
infrared application.
Only exchange electrical components
with original components from the
manufacturer. All repairs must be
performed by an engineer qualified by
b-intense
must not be opened.
. The electrical components
®
Ensure that the heater is not covered and
that there are no objects placed on it.
Ensure that your hair does not touch
the heater while it is in operation.
Tie your hair up to have your back
completely free.
Children are not allowed to play with
the device or to carry out any repairs,
cleaning or maintenance work.
Patients with limited sensation of heat
and patients under the effects of alcohol,
drugs or tranquilizers are not allowed to
use the cabin.
Reduce the intensity of the back heater
immediately, if you feel burning or pain
in the radiated area.
If you experience any discomfort, stop
your infrared treatment immediately!
If overheating occurs or if you feel the
temperature is too high, you can reduce
the radiation intensity or open the door
and switch on the ventilation.
Consult your doctor on your own respon-
sibility concerning your infrared treatment
after operations, in case of illness, injuries,
pregnancy or in the case of implants (e.g.
after plastic or orthopedic surgery), also in
any case that involves a risk of overhea-
ting, such as patients with cardiovascular
diseases or while taking medication.
39 39
EN